Abstract
MicroRNAs (miR) are small non-coding RNAs that bind to specific mRNA targets and promote their degradation or inhibit translation. In this book chapter, we reviewed the roles of multiple miRNAs, which are involved in the pathogenesis of alcohol-related liver disease (ALD). We also briefly discuss the roles of miRNAs as the mediators for inter-organ crosstalk and the development of ALD. We provided clues for the potential clinical applications of miRNAs as the prognostic markers and the future perspectives on the use of miRNA-based strategy for the treatment of patients with ALD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Huang T, Chen L, Song J, et al. Integrated analysis of multiscale large-scale biological data for investigating human disease 2016. Biomed Res Int. 2016;2016:6585069.
Pogue AI, Clement C, Hill JM, et al. Evolution of microRNA (miRNA) structure and function in plants and animals: relevance to aging and disease. J Aging Sci. 2014:2.
Macfarlane LA, Murphy PR. MicroRNA: biogenesis, function and role in cancer. Curr Genomics. 2010;11:537–61.
O'Brien J, Hayder H, Zayed Y, et al. Overview of MicroRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018;9:402.
Wahid F, Shehzad A, Khan T, et al. MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim Biophys Acta. 2010;1803:1231–43.
Mullokandov G, Baccarini A, Ruzo A, et al. High-throughput assessment of microRNA activity and function using microRNA sensor and decoy libraries. Nat Methods. 2012;9:840–6.
Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–33.
Osterndorff-Kahanek EA, Tiwari GR, Lopez MF, et al. Long-term ethanol exposure: temporal pattern of microRNA expression and associated mRNA gene networks in mouse brain. PLoS One. 2018;13:e0190841.
Mandrekar P. Epigenetic regulation in alcoholic liver disease. World J Gastroenterol. 2011;17:2456–64.
Miranda RC, Pietrzykowski AZ, Tang Y, et al. MicroRNAs: master regulators of ethanol abuse and toxicity? Alcohol Clin Exp Res. 2010;34:575–87.
Bala S, Petrasek J, Mundkur S, et al. Circulating microRNAs in exosomes indicate hepatocyte injury and inflammation in alcoholic, drug-induced, and inflammatory liver diseases. Hepatology. 2012;56:1946–57.
Mandrekar P, Bataller R, Tsukamoto H, et al. Alcoholic hepatitis: translational approaches to develop targeted therapies. Hepatology. 2016;64(4):1343–55.
Sarin SK, Pande A, Schnabl B. Microbiome as a therapeutic target in alcohol-related liver disease. J Hepatol. 2019;70:260–72.
Gao B, Ahmad MF, Nagy LE, et al. Inflammatory pathways in alcoholic steatohepatitis. J Hepatol. 2019;70:249–59.
Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A. 2011;108:5003–8.
Natarajan SK, Pachunka JM, Mott JL. Role of microRNAs in alcohol-induced multi-organ injury. Biomol Ther. 2015;5:3309–38.
Wang X, He Y, Mackowiak B, et al. MicroRNAs as regulators, biomarkers and therapeutic targets in liver diseases. Gut. 2021;70:784–95.
Yang Z, Zhang T, Kusumanchi P, et al. Transcriptomic analysis reveals the MicroRNAs responsible for liver regeneration associated with mortality in alcohol-associated hepatitis. Hepatology. 2021;74:2436–51.
Kumarswamy R, Volkmann I, Thum T. Regulation and function of miRNA-21 in health and disease. RNA Biol. 2011;8:706–13.
Zhang T, Yang Z, Kusumanchi P, et al. Critical role of microRNA-21 in the pathogenesis of liver diseases. Front Med (Lausanne). 2020;7:7.
Zhu H, Luo H, Li Y, et al. MicroRNA-21 in scleroderma fibrosis and its function in TGF-beta-regulated fibrosis-related genes expression. J Clin Immunol. 2013;33:1100–9.
Beltrami C, Besnier M, Shantikumar S, et al. Human pericardial fluid contains exosomes enriched with cardiovascular-expressed MicroRNAs and promotes therapeutic angiogenesis. Mol Ther. 2017;25:679–93.
Sun C, Huang F, Liu X, et al. miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR. Int J Mol Med. 2015;35:847–53.
Francis H, McDaniel K, Han Y, et al. Regulation of the extrinsic apoptotic pathway by microRNA-21 in alcoholic liver injury. J Biol Chem. 2014;289:27526–39.
Wu N, McDaniel K, Zhou T, et al. Knockout of microRNA-21 attenuates alcoholic hepatitis through the VHL/NF-kappaB signaling pathway in hepatic stellate cells. Am J Physiol Gastrointest Liver Physiol. 2018;315:G385–98.
Srivastava A, Parrish A, Hoek JB, et al. Modulation of miR-21 can reprogram the TGF-beta signaling pathway to alter HSC phenotype in vitro. FASEB J. 2022;36(Suppl):1.
Kota J, Chivukula RR, O'Donnell KA, et al. Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model. Cell. 2009;137:1005–17.
Zhang J, Han C, Wu T. MicroRNA-26a promotes cholangiocarcinoma growth by activating beta-catenin. Gastroenterology. 2012;143:246–56.e8.
Witwer KW, Sisk JM, Gama L, et al. MicroRNA regulation of IFN-beta protein expression: rapid and sensitive modulation of the innate immune response. J Immunol. 2010;184:2369–76.
Zhou J, Ju W, Wang D, et al. Down-regulation of microRNA-26a promotes mouse hepatocyte proliferation during liver regeneration. PLoS One. 2012;7:e33577.
Han W, Fu X, Xie J, et al. MiR-26a enhances autophagy to protect against ethanol-induced acute liver injury. J Mol Med (Berl). 2015;93:1045–55.
Prins SA, Przybycien-Szymanska MM, Rao YS, et al. Long-term effects of peripubertal binge EtOH exposure on hippocampal microRNA expression in the rat. PLoS One. 2014;9:e83166.
Saha B, Bruneau JC, Kodys K, et al. Alcohol-induced miR-27a regulates differentiation and M2 macrophage polarization of normal human monocytes. J Immunol. 2015;194:3079–87.
Saha B, Momen-Heravi F, Kodys K, et al. MicroRNA cargo of extracellular vesicles from alcohol-exposed monocytes signals naive monocytes to differentiate into M2 macrophages. J Biol Chem. 2016;291:149–59.
Santos-Bezerra DP, Cavaleiro AM, Santos AS, et al. Alcohol use disorder is associated with upregulation of MicroRNA-34a and MicroRNA-34c in hippocampal postmortem tissue. Alcohol Clin Exp Res. 2021;45:64–8.
Piccolo P, Ferriero R, Barbato A, et al. Up-regulation of miR-34b/c by JNK and FOXO3 protects from liver fibrosis. Proc Natl Acad Sci U S A. 2021:118.
Liu H, French BA, Li J, et al. Altered regulation of miR-34a and miR-483-3p in alcoholic hepatitis and DDC fed mice. Exp Mol Pathol. 2015;99:552–7.
Fan H, Yuan F, Yun Y, et al. MicroRNA-34a mediates ethanol-induced impairment of neural differentiation of neural crest cells by targeting autophagy-related gene 9a. Exp Neurol. 2019;320:112981.
Meng F, Glaser SS, Francis H, et al. Epigenetic regulation of miR-34a expression in alcoholic liver injury. Am J Pathol. 2012;181:804–17.
Wan Y, McDaniel K, Wu N, et al. Regulation of cellular senescence by miR-34a in alcoholic liver injury. Am J Pathol. 2017;187:2788–98.
Xu H, He JH, Xiao ZD, et al. Liver-enriched transcription factors regulate microRNA-122 that targets CUTL1 during liver development. Hepatology. 2010;52:1431–42.
Satishchandran A, Ambade A, Rao S, et al. MicroRNA 122, regulated by GRLH2, protects livers of mice and patients from ethanol-induced liver disease. Gastroenterology. 2018;154(238–252):e7.
Teng KY, Barajas JM, Hu P, et al. Role of B cell lymphoma 2 in the regulation of liver fibrosis in miR-122 knockout mice. Biology (Basel). 2020:9.
Long JK, Dai W, Zheng YW, et al. miR-122 promotes hepatic lipogenesis via inhibiting the LKB1/AMPK pathway by targeting Sirt1 in non-alcoholic fatty liver disease. Mol Med. 2019;25:26.
Pasqualotto A, Ayres R, Longo L, et al. Chronic exposure to ethanol alters the expression of miR-155, miR-122 and miR-217 in alcoholic liver disease in an adult zebrafish model. Biomarkers. 2021;26:146–51.
Zhang Q, Yu K, Cao Y, et al. miR-125b promotes the NF-kappaB-mediated inflammatory response in NAFLD via directly targeting TNFAIP3. Life Sci. 2021;270:119071.
Zhang ZC, Liu Y, Xiao LL, et al. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice. J Hepatol. 2015;63:1466–75.
Hu Z, Li L, Ran J, et al. miR-125b acts as anti-fibrotic therapeutic target through regulating Gli3 in vivo and in vitro. Ann Hepatol. 2019;18:825–32.
Bala S, Csak T, Saha B, et al. The pro-inflammatory effects of miR-155 promote liver fibrosis and alcohol-induced steatohepatitis. J Hepatol. 2016;64:1378–87.
Bala S, Szabo G. MicroRNA signature in alcoholic liver disease. Int J Hepatol. 2012;2012:498232.
Chen X, Liu J, Feng WK, et al. MiR-125b protects against ethanol-induced apoptosis in neural crest cells and mouse embryos by targeting Bak 1 and PUMA. Exp Neurol. 2015;271:104–11.
Ren L, Qv A, Liu Y, et al. Downregulation of miR-129-5p alleviates alcohol-induced barrier dysfunction of Caco-2 human intestinal epithelial cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2019;35:892–6.
Zhang Z, Wen H, Peng B, et al. Downregulated microRNA-129-5p by Long non-coding RNA NEAT1 upregulates PEG3 expression to aggravate non-alcoholic steatohepatitis. Front Genet. 2020;11:563265.
Ye J, Lin Y, Yu Y, et al. LncRNA NEAT1/microRNA-129-5p/SOCS2 axis regulates liver fibrosis in alcoholic steatohepatitis. J Transl Med. 2020;18:445.
Lin X, Jia J, Du T, et al. Overexpression of miR-155 in the liver of transgenic mice alters the expression profiling of hepatic genes associated with lipid metabolism. PLoS One. 2015;10:e0118417.
Csak T, Bala S, Lippai D, et al. MicroRNA-155 deficiency attenuates liver steatosis and fibrosis without reducing inflammation in a mouse model of steatohepatitis. PLoS One. 2015;10:e0129251.
Bala S, Marcos M, Kodys K, et al. Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease. J Biol Chem 2011;286:1436–1444.
Bala S, Csak T, Kodys K, et al. Alcohol-induced miR-155 and HDAC11 inhibit negative regulators of the TLR4 pathway and lead to increased LPS responsiveness of Kupffer cells in alcoholic liver disease. J Leukoc Biol. 2017;102:487–98.
Saikia P, Bellos D, McMullen MR, et al. MicroRNA 181b-3p and its target importin alpha5 regulate toll-like receptor 4 signaling in Kupffer cells and liver injury in mice in response to ethanol. Hepatology. 2017;66:602–15.
Wang W, Zhong GZ, Long KB, et al. Silencing miR-181b-5p upregulates PIAS1 to repress oxidative stress and inflammatory response in rats with alcoholic fatty liver disease through inhibiting PRMT1. Int Immunopharmacol. 2021;101:108151.
Wang Y, Zhu K, Yu W, et al. MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1. Biochem Biophys Res Commun. 2017;493:227–32.
Blaya D, Coll M, Rodrigo-Torres D, et al. Integrative microRNA profiling in alcoholic hepatitis reveals a role for microRNA-182 in liver injury and inflammation. Gut. 2016;65:1535–45.
Zuo Z, Li Y, Zeng C, et al. Integrated analyses identify key molecules and reveal the potential mechanism of miR-182-5p/FOXO1 Axis in alcoholic liver disease. Front Med (Lausanne). 2021;8:767584.
Yeligar S, Tsukamoto H, Kalra VK. Ethanol-induced expression of ET-1 and ET-BR in liver sinusoidal endothelial cells and human endothelial cells involves hypoxia-inducible factor-1alpha and microrNA-199. J Immunol. 2009;183:5232–43.
Feng J, Wang J, Chen M, et al. miR-200a suppresses cell growth and migration by targeting MACC1 and predicts prognosis in hepatocellular carcinoma. Oncol Rep. 2015;33:713–20.
Zhao YX, Sun YY, Huang AL, et al. MicroRNA-200a induces apoptosis by targeting ZEB2 in alcoholic liver disease. Cell Cycle. 2018;17:250–62.
Tang Y, Banan A, Forsyth CB, et al. Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. Alcohol Clin Exp Res. 2008;32:355–64.
Han D, Hanawa N, Saberi B, et al. Mechanisms of liver injury. III. Role of glutathione redox status in liver injury. Am J Physiol Gastrointest Liver Physiol. 2006;291:G1–7.
Dong X, Liu H, Chen F, et al. MiR-214 promotes the alcohol-induced oxidative stress via down-regulation of glutathione reductase and cytochrome P450 oxidoreductase in liver cells. Alcohol Clin Exp Res. 2014;38:68–77.
Zangar RC, Davydov DR, Verma S. Mechanisms that regulate production of reactive oxygen species by cytochrome P450. Toxicol Appl Pharmacol. 2004;199:316–31.
Xiang H, Tu B, Luo M, et al. Knockdown of UCA1 attenuated the progression of alcoholic fatty disease by sponging miR-214. Mamm Genome. 2022;33:534–42.
Yin H, Hu M, Zhang R, et al. MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1. J Biol Chem. 2012;287:9817–26.
Yin H, Liang X, Jogasuria A, et al. miR-217 regulates ethanol-induced hepatic inflammation by disrupting Sirtuin 1-Lipin-1 signaling. Am J Pathol. 2015;185(5):1286–96.
Johnnidis JB, Harris MH, Wheeler RT, et al. Regulation of progenitor cell proliferation and granulocyte function by microRNA-223. Nature. 2008;451:1125–9.
Li M, He Y, Zhou Z, et al. MicroRNA-223 ameliorates alcoholic liver injury by inhibiting the IL-6-p47(phox)-oxidative stress pathway in neutrophils. Gut. 2017;66:705–15.
El-Benna J, Dang PM, Gougerot-Pocidalo MA, et al. p47phox, the phagocyte NADPH oxidase/NOX2 organizer: structure, phosphorylation and implication in diseases. Exp Mol Med. 2009;41:217–25.
Ren R, He Y, Ding D, et al. Aging exaggerates acute-on-chronic alcohol-induced liver injury in mice and humans by inhibiting neutrophilic sirtuin 1-C/EBPalpha-miRNA-223 axis. Hepatology. 2022;75:646–60.
Saikia P, Roychowdhury S, Bellos D, et al. Hyaluronic acid 35 normalizes TLR4 signaling in Kupffer cells from ethanol-fed rats via regulation of microRNA291b and its target Tollip. Sci Rep. 2017;7:15671.
McDaniel K, Huang L, Sato K, et al. The let-7/Lin28 axis regulates activation of hepatic stellate cells in alcoholic liver injury. J Biol Chem. 2017;292:11336–47.
Massey VL, Qin L, Cabezas J, et al. TLR7-let-7 signaling contributes to ethanol-induced hepatic inflammatory response in mice and in alcoholic hepatitis. Alcohol Clin Exp Res. 2018;42:2107–22.
Momen-Heravi F, Bala S, Kodys K, et al. Exosomes derived from alcohol-treated hepatocytes horizontally transfer liver specific miRNA-122 and sensitize monocytes to LPS. Sci Rep. 2015;5:9991.
Ambade A, Satishchandran A, Szabo G. Alcoholic hepatitis accelerates early hepatobiliary cancer by increasing stemness and miR-122-mediated HIF-1alpha activation. Sci Rep. 2016;6:21340.
Chen YP, Jin X, Kong M, et al. Pattern of microRNA expression associated with different stages of alcoholic liver disease in rat models. Mol Med Rep. 2014;10:1195–204.
Chakraborty C, Sharma AR, Sharma G, et al. Therapeutic advances of miRNAs: a preclinical and clinical update. J Adv Res. 2021;28:127–38.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Ethics declarations
None of the authors have any conflicts of interest with this work.
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Perez, K., Ma, J., Huda, N., Yang, Z., Liangpunsakul, S. (2023). MicroRNAs and Alcohol-Related Liver Disease. In: Mueller, S., Heilig, M. (eds) Alcohol and Alcohol-related Diseases. Springer, Cham. https://doi.org/10.1007/978-3-031-32483-3_60
Download citation
DOI: https://doi.org/10.1007/978-3-031-32483-3_60
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-32482-6
Online ISBN: 978-3-031-32483-3
eBook Packages: MedicineMedicine (R0)